Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update

Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update

PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American:CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced financial r…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *